ArticleNature communications2025
Engineered microbial platform confers resistance against heavy metals via phosphomelanin biosynthesis.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- To Biotic or Abiotic: Biohybrid Systems for Artificial Photosynthesis.Chemical reviews · 2026Review
- Microbial melanin: biosynthesis, functional Insights, and emerging research challenges.World journal of microbiology & biotechnology · 2026Review
- Review
- From detection to remediation: the potential of phosphomelanin in sustainable environmental solutions.Frontiers in bioengineering and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Environmental concerns are increasingly fueling interest in engineered living materials derived from microbial sources. Melanin biosynthesis in microbes, particularly facilitated by recombinant tyrosinase expression, offers sustainable protection for the habitat of microorganisms against severe environmental stressors. However, there exists a vast urgency to optimize these engineered microbial platforms, which will amplify their protective capabilities, integrate multifaceted functions, and thereby expand their utility and effectiveness. Here, we genetically engineer microbial platforms capable of endogenously biosynthesizing phosphomelanin, a unique phosphorus-containing melanin. The ability to heterogeneously biosynthesize phosphomelanin endows the microbes with enhanced resistance to heavy metals, thus safeguarding their survival in adverse conditions. Furthermore, we upgrade these engineered microbes by integrating PET-degrading enzymes, thereby achieving effective integrated management of metallized plastic waste. This engineered microbial platform, with its phosphomelanin biosynthetic capabilities, presents significant opportunities for microbes to engage in bioengineering manufacturing, potentially serving as the next-generation guardians against global ecological challenges.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.